REG - Abingdon Health PLC - Directorate Change

Abingdon HealthAnnouncement

19/12/2024 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241219:nRSS6515Qa&default-theme=true

RNS Number : 6515Q  Abingdon Health PLC  19 December 2024

 

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

 

Directorate Change

Appointment of Chief Financial Officer

 

York, U.K. 19 December 2024: Abingdon Health plc (AIM: ABDX), a leading
international lateral flow contract research (CRO) and contract development
and manufacturing organisation (CDMO), announces the appointment of Tom Hayes
as Chief Financial Officer ("CFO") and a Director of the Company. Tom will
join Abingdon on 6 January 2025 on a part-time basis and will assume the
full-time position by April 2025.

 

Tom has significant capital markets experience having spent the last ten years
as Group Finance Director at Northern Bear plc, an AIM-listed Group of ten
specialist building services companies assembled through an acquisition
strategy. Tom has previously held roles at Sentio Insight LLP, a boutique
advisory firm, providing a range of financial due diligence and transaction
services, and Ernst & Young LLP, gaining corporate finance advisory
experience in the private equity, corporate and public sectors. Tom qualified
as a Chartered Accountant with Arthur Andersen & Co.

 

Tom Hayes

Chief Financial Officer of Abingdon Health plc

 

Dr Chris Hand, Executive Chairman of Abingdon Health plc, commented: "I am
delighted to welcome Tom to Abingdon Health plc as CFO and board director.
This is a key time for Tom to join as we continue our growth, consolidate our
recent acquisitions and expand our activities into the USA via our Madison, WI
base. Tom has over 25 years' experience, particularly with AIM-listed
companies, having worked as Group Finance Director at Northern Bear plc and
prior to this in advisory roles. 2025 is going to be an exciting year for
Abingdon with our upcoming growth plans and Tom with his expertise will be a
great addition to the business."

 

Additional Disclosures Required under the AIM Rules for Companies

Thomas Edward Hayes (aged 48) has held the following directorship or
partnerships in the past five years:

 

 Current directorships/partnerships  Previous directorships/partnerships (last five years)

 Springs Roofing Limited             Sab Invest LLP (Dissolved)

 Alcor Handling Solutions Limited    Lister Holdings (York) Limited (Dissolved)

 H. Peel & Sons Limited              Jennings Properties Limited (Dissolved)

 J Lister Electrical Limited         H Peel & Sons (Holdings) Limited (Dissolved)

 Isoler Limited                      Maxaim Strategic and Financial Management Limited (Dissolved)

 Jennings Roofing Limited
 Arcas Building Solutions Limited
 Northern Bear (Safety) Limited
 Wensley Roofing Limited
 MGM Limited
 Northern Bear plc
 SH Consultancy Oakwood Limited
 Sentio Insight LLP
 A1 Industrial Trucks Limited
 System Roofing Services Limited
 Northern Bear Construction Limited
 Northern Bear Roofing Limited
 Joom LLP

 

Tom Hayes and persons closely associated (as defined under MAR) with Mr Hayes
do not hold any shares in the Company.

 

Save as disclosed above, there is no further information to be disclosed in
respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph
(g) of the AIM Rules for Companies.

 

Enquiries:

 

 Abingdon Health plc                           www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
 Chris Yates, Chief Executive Officer                                      Via Walbrook PR
 Chris Hand, Executive Chairman

 Zeus (Sole Broker and Nominated Adviser)                                    Tel: +44 (0)20 3829 5000
 Chris Fielding / Alexandra Campbell-Harris (Corporate Finance)
 Fraser Marshall (Corporate Broking)

 Walbrook PR (Media & Investor Relations)      Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
                                               (mailto:abingdon@walbrookpr.com)
 Paul McManus / Alice Woodings                 Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
 Phillip Marriage                              +44 (0)7867 984 082

 

 

About Abingdon Health plc

Abingdon Health Group is a leading med-tech contract service provider
offering its services to an international customer base.

 

The Company's CDMO division
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.abingdonhealth.com_services_&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=HA76POaNPDBWSuSNqpvm6h6sTVAmwDfGPxyLLvvNBHg&e=)
 offers lateral flow product development, regulatory support, technology
transfer and manufacturing services for customers looking to develop new
assays or transfer existing laboratory-based assays to a lateral flow
format. Abingdon Health's CDMO division has the internal capabilities to
take lateral flow projects, in areas such as infectious disease and clinical
testing, including companion diagnostics, animal health and environmental
testing, from initial concept through to routine and large-scale
manufacturing; from "idea to commercial success".

 

Abingdon's regulatory services companies, Compliance Solutions (Life
Sciences)
(https://urldefense.proofpoint.com/v2/url?u=https-3A__cslifesciences.com&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=PvbE1xuJgNrAaK0I9QSrYjO3acai4ITHsbheoH-Cavc&e=)
 and IVDeology
(https://urldefense.proofpoint.com/v2/url?u=https-3A__www.ivdeology.co.uk&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=mbRruUP_NEre93fFYpNkBweGVcmSCnXpjUyMQmUx1yI&e=)
, provide a broad range of regulatory services to the in vitro diagnostic and
wider medical device industry, to support customers in bringing products to
market across a range of territories including the USA, EU and the UK. Our
consultancy services range from design, implementation and maintenance of
quality management systems, preparation of technical files for regulatory
approvals, part-time and interim management support, auditing both internal
and external, management reviews and presentations, training and mentoring.

 

Abingdon Health's Abingdon Simply Test range of self-tests is an e-commerce
platform that offers a range of self-tests to empowers consumers to manage
their own health and wellbeing. The Abingdon Simply Test
(https://urldefense.proofpoint.com/v2/url?u=http-3A__www.abingdonsimplytest.com&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=71SLyhJsm1hJqJvXuK0jPc4-fr_IZIW_VOOfo4sJwQw&e=)
 e-commerce site offers consumers a range of information to support them in
making informed decisions on the tests available. In addition, the site
provides Abingdon's contract services customers with a potential route to
market for self-tests. The Abingdon Simply Test range is also sold through
international distributors and through other channels in
the UK and Ireland, such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com
(https://urldefense.proofpoint.com/v2/url?u=http-3A__www.abingdonhealth.com_&d=DwMFAg&c=euGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM&r=b40MoFA_Q_fdsT77LXB5t3JFUZjlmpd2MVbmgvoBIOo&m=5rmPWmSeAYNtvo-wVGL_4V7p0wZ2qRPhbqDj6E6FHnhVakMVyzvk7wZG1jS6vI4P&s=Cd1Yy0EoU5vx33xedoTE3bCKbljgDOIRD8ol-bb59BM&e=)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAMZMMZNRDGDZM